Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients

Podobne zapisy

• Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
  od: Villani, P, i wsp.
  Wydane: (2006)
• Clinical Pharmacokinetics of Nelfinavir and Its Metabolite M8 in Human Immunodeficiency Virus (HIV)-Positive and HIV-Hepatitis C Virus-Coinfected Subjects
  od: Regazzi, Mario, i wsp.
  Wydane: (2005)
• Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteers
  od: la Porte, C J L, i wsp.
  Wydane: (2004)
• Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naïve, Human Immunodeficiency Virus-Infected Subjects when Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors
  od: Smith, Patrick F., i wsp.
  Wydane: (2005)
• Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients
  od: Trabattoni, Daria, i wsp.
  Wydane: (2002)